StevanAGonzalezMD

Hepatology & Liver Transplantation

Medical Director of Liver Transplantation

Dr. Gonzalez is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1250 8th Ave
Ste 515
Fort Worth, TX 76104
Phone+1 817-922-4675

Fax+1 817-922-4645

Stevan Gonzalez, MD is a seasoned gastroenterologist based in Fort Worth, Texas with subspecialty in Hepatology and Liver Transplantation. Dr. Gonzalez received his medical education from various renowned institutions including New York Presbyterian Hospital and Stanford Health Care, and also holds an MS in Biostatistics from the Columbia Mailman School of Public Health. He is experienced in managing a variety of conditions including complications of cirrhosis, viral hepatitis, autoimmune liver disease, and both alcoholic and non-alcoholic fatty liver disease. Dr. Gonzalez has contributed to significant research in his field, demonstrated by his numerous publications and involvement in clinical trials. He has maintained an active role in organ transplantation as a member of the OPTN/UNOS Living Donor Committee since 2019, currently serving as Chair. He is also active in medical education as Professor in the Department of Medicine at the Burnett School of Medicine at TCU.

Stanford Health CareFellowship, Transplant Hepatology, 2007 - 2008
Columbia Mailman School of Public HealthMS, Biostatistics, 2005 - 2007
New York Presbyterian Hospital (Cornell Campus)Fellowship, Gastroenterology, 2004 - 2007
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2000 - 2003
Geisel School of Medicine at DartmouthClass of 2000

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

PubMed

Safety and efficacy of continuous terlipressin infusion in HRS-AKI in a transplant population.
K Rajender Reddy, Ethan M Weinberg, Stevan A Gonzalez, Manhal J Izzy, Douglas A Simonetto
Liver Transplantation. 2024-10-01
Prospective evaluation of cystatin C in the assessment of kidney dysfunction and survival in liver transplant candidates.
Stevan A Gonzalez, Nagasri Shankar, Ashwini Mehta, Mauricio Garcia-Saenz-de-Sicilia, Goran B Klintmalm
Liver Transplantation. 2024-09-24
Priority for kidney after liver transplantation: A safety net for all?
Stevan A Gonzalez, Sumeet K Asrani
Liver Transplantation. 2024-06-01

Journal Articles

INFUSE: Rationale and Design of a Multi-Center, Open Label, Collaborative Study to Treat HRS-AKI with Continuous Terlipressin Infusion.
Weinberg E, Rahematpura S, Gonzalez SA, Izzy MJ, Simonetto DA, Frederick RT, Rubin RA, Ikahihifo-Bender J, Harte, M, Kim-Lee G, Witkiewicz S, Tobin W, Jamil K, Fricker..., Contemporary Clinical Trials Communications
Terlipressin versus Midodrine plus Octreotide for Hepatorenal Syndrome-Acute Kidney Injury: A Propensity Score-Matched Comparison.
Gonzalez SA, Chirikov VV, Wang WJ, Huang X, Jamil K, Simonetto DA., Clinical and Translational Gastroenterology
A Model for Glomerular Filtration Rate Assessment in Liver Disease (GRAIL) in the Presence of Renal Dysfunction
Bernard Fischbach, James F Trotter, W R Kim, Stevan A Gonzalez, Goran Klintmalm, Sumeet K Asrani, Michael Emmett, Ranjeeta Bahirwani, Josh Levitsky, Mitra K Nadim, Hepatology

Smartphone App to Assess Stool Form, Rural-Urban Disparities in Cirrhosis Mortality, Lung Infection Risk in Severe Alcoholic Hepatitis in July Issue of AJGJuly 5th, 2022
COMMENTARY: COVID Collaboration: Working Group Demonstrates Potential for InnovationMarch 19th, 2021